States that support access to health information can decrease colon cancer deaths

September 26, 2012 by Sharyn Alden

Despite medical advances in colon cancer screening and treatment, people with a lower socioeconomic status remain at a higher risk of dying from colon cancer. A new study in The Milbank Quarterly finds that states and communities that focus on increasing the adoption of innovative health care practices along with providing greater access to public health information can reduce these deaths. 

This year, over 50,000 people in the U.S. are projected to die from and one in 20 people will be diagnosed with the disease.  Since colon cancer usually progresses over 7 to 10 years before becoming deadly, early detection and treatment can save numerous lives. 

"But because people do not seek or are blocked from seeking preventive treatments, this can have deadly consequences for many," said the study's lead author, Andrew C. Wang, M.P.H., at Columbia University's Mailman School of Public Health, New York. "However, our results are hopeful in this sense. They suggest that we could attack this problem by more efficiently diffusing this information to those who are least likely to access it on their own."

Researchers identified U.S. patients who died from colorectal cancer between 1968 and 2008 and examined socioeconomic (SES) and differences in state levels of health information diffusion. States with policies designed to promote health care innovation and the effective diffusion of health information to the public and clinicians have been previously linked to improvement in .

The researchers found that deaths from colon cancer in the highest SES counties decreased over the 40 year period while deaths increased in lower SES counties. In addition, states with high rates of diffusion had substantial declines in deaths, while states with low diffusion had comparatively lower declines. Notably, higher rates of health lessened the impact of low SES on colon cancer deaths.

Encouraging the faster spread of information "at all levels of society, including patients and providers, may have a large impact on reducing both colorectal cancer mortality and the social inequalities observed in colorectal cancer mortality," the researchers wrote.

Mark E. Benson, M.D., assistant professor of gastroenterology and endoscopy at the University of Wisconsin, School of Medicine and said, "The study was interesting in that while it is well known that socioeconomic factors often play a part in having access to colon , a consumer's motivation to seek information regardless of whether they have access to health insurance also plays a part in cancer prevention."

Benson pointed out that with so much information available to consumers via the Internet, medical sources and intra-personal relationships today it is surprising that there is a disparity of education about colon cancer.

"Yet, I see that disparity all the time in my practice," he said. "Some patients are well informed prior to the screening procedure and others are not. Educating patients about the importance of is a complicated process but vitally important because it can save lives."

Wang added, "Not everyone has the resources to pay for preventive services, but to increase population health we need to improve outcomes among individuals who are less likely to hear about, discuss and use information to its maximum capacity."

Explore further: Racial disparities in colon cancer screening persist despite insurance, access

More information: Wang, A. et al. 2012. Fundamental Causes of Colorectal Cancer Mortality: The Implications of Informational Diffusion, The Milbank Quarterly, Vol. 90, No. 3, 592–618.

Related Stories

Racial disparities in colon cancer screening persist despite insurance, access

December 12, 2011
Public health researchers have long attributed the disparity in colonoscopy rates between whites and minorities to a lack of health insurance or access to doctors. Now, a new study suggests the reasons for the differences ...

Alcohol consumption and risk of colon cancer in people with a family history of such cancer

January 30, 2012
A study based on more than 87,000 women and 47,000 men in the Nurses' Health Study and the Health Professionals Follow-up Study, looks at whether there is a link between colon cancer and alcohol, and if so at what level of ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.